Key result
Endovascular splanchnic nerve ablation fails to lower peak exercise or resting PCWP in HFpEF.
Why the study?
Patients with HFpEF have incompletely understood autonomic pathophysiology, and splanchnic nerve ablation emerges as a potential option to modulate the nervous system and impact exercise capacity.
Does endovascular ablation of the splanchnic nerve reduce pulmonary capillary wedge pressure in patients with heart failure with preserved ejection fraction?
Meta-Analysis (n=62)
Does endovascular ablation of the splanchnic nerve reduce pulmonary capillary wedge pressure in patients with heart failure with preserved ejection fraction?
Endovascular splanchnic nerve ablation did not significantly reduce peak exercise or resting pulmonary capillary wedge pressure in patients with HFpEF in this single-arm meta-analysis.
Answers are grounded in this paper and cite their sources.
Does not support splanchnic nerve ablation to lower PCWP in HFpEF; leaves open efficacy in larger RCTs.
Background Patients with heart failure with preserved ejection fraction have a complex and not fully understood pathophysiology regarding the modulation of the autonomic nervous system. In this patient profile, splanchnic nerve ablation emerges as a potential therapeutic option, assessing nervous system modulation, and impacting exercise capacity and quality of life. Purpose We aimed to conduct a single-arm meta-analysis to assess the safety and effectiveness of endovascular ablation in splanchnic nerve in patients with heart failure with preserved ejection fraction. Methods We systematically searched PubMed, Embase, and Cochrane databases for randomized controlled trials (RCTs) and observational studies reporting the efficacy and safety of endovascular ablation of splanchnic nerve in heart failure with preserved ejection fraction. The outcomes analyzed were pulmonary capillary wedge pressure (PCWP) in peak exercise and PCWP in resting. Statistical analyses were performed using R software version 5.4.1. We assessed mean differences (MD) for continuous outcomes and subgroup analysis comparing baseline and least time of follow-up under a random effects model with 95% Confidence Intervals (CI), with a p-value < 0.05 considered for statistical significance. Results Four studies were selected, including two randomized clinical trials (RCTs) and two observational studies. A subgroup analysis was conducted to assess the changes before and after splanchnic nerve ablation in pulmonary capillary wedge pressure (PCWP) peak exercise and resting from baseline to the shortest follow-up period. For peak exercise PCWP, 60 patients were assessed at baseline with a mean of 32.26 [25.16 - 39.37]. At the shortest follow-up, 62 patients were assessed with a mean of 26.16 [17.72 - 34.59]. Likewise, at baseline, the patients presented a resting PCWP mean of 21.01 [13.93; 28.09], and at the shortest follow-up mean, a mean of 16.27 [12.21; 20.33]. Conclusion This systematic review and meta-analysis found no significant difference in PCWP at peak exercise or at rest before and after endovascular splanchnic nerve ablation in HFpEF patients. However, given the novelty of this therapeutic approach, further large-scale RCTs with longer follow-up periods are needed to better assess long-term outcomes, refine PCWP measurement, and optimize patient management.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2025) conducted a meta-analysis in Heart failure with preserved ejection fraction (HFpEF) (n=62). Endovascular ablation of splanchnic nerve vs. Baseline (before ablation) was evaluated on Pulmonary capillary wedge pressure (PCWP) at peak exercise. Endovascular splanchnic nerve ablation resulted in no significant difference in pulmonary capillary wedge pressure at peak exercise or at rest compared to baseline in patients with HFpEF.
Synapse has enriched 10 related papers. Consider them for comparative context: